Cite
HARVARD Citation
Major, G. et al. (2019). Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial. Gut. 68 (7), pp. 1224-1231. [Online].